DAPINAQ- salicylic acid cream

Dapinaq by

Drug Labeling and Warnings

Dapinaq by is a Otc medication manufactured, distributed, or labeled by METHODIQ INC.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredients

Salicylic Acid 0.5%

Purpose

Salicylic Acid 0.5%.......................Acne Treatment

Uses

• For the management / treatment of acne.
• Clears acne blemishes and blackheads.
• Helps prevent the development of new acne blemishes and blackheads.

Warnings

For external use only

When using this product
Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.
If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

• Clean the skin thoroughly before applying this product.
• Cover the entire affected area with a thin layer one to three times daily.
• Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
• If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Inactive ingredients

Water, Aloe Barbadensis Leaf Juice, Squalane, C13-15 Alkane (Hemisqualane), Glycerin, Propanediol, Cetyl Ethylhexanoate, Diheptyl Succinate, Butylene Glycol, Polyacrylate Crosspolymer-6, Oleyl Adapalenate, Niacinamide, Tripeptide-1, Polylysine, Acetyl Glucosamine, Sodium Hyaluronate, Cetearyl Olivate, Sorbitan Olivate, Sodium Stearoyl Glutamate, Epilobium Angustifolium Flower/Leaf/Stem Extract, Polydextrose, Dextran, Dextrin, Amylopectin, Capryloyl Glycerin/Sebacic Acid Copolymer, Hydroxyacetophenone, Sodium Benzoate, Sodium Hydroxide, Potassium Sorbate, Citric Acid, Triethyl Citrate, Phenethyl Alcohol, 2,6-Dimethyl-7-Octen-2-ol, Benzyl Acetate, Heliotropine, 3-Hexenol, Gamma-Undecalactone

PRINCIPAL DISPLAY PANEL

15ml

0.5 Fl. Oz.

Dapinaq

Salicylic Acid Acne Treatment

INGREDIENTS AND APPEARANCE

DAPINAQ 
salicylic acid cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 87110-002
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	5 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
ACETYL GLUCOSAMINE (UNII: V956696549)
WATER (UNII: 059QF0KO0R)
PROPANEDIOL (UNII: 5965N8W85T)
POLYACRYLATE CROSSPOLYMER-6 (UNII: Q7UI015FF9)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
SORBITAN OLIVATE (UNII: MDL271E3GR)
GLYCERIN (UNII: PDC6A3C0OX)
NIACINAMIDE (UNII: 25X51I8RD4)
BENZYL ACETATE (UNII: 0ECG3V79ZJ)
ALOE BARBADENSIS LEAF JUICE (UNII: RUE8E6T4NB)
SQUALANE (UNII: GW89575KF9)
OLEYL ADAPALENATE (UNII: GRS4SNP9WC)
TRIPEPTIDE-1 (UNII: 39TG2H631E)
SODIUM STEAROYL GLUTAMATE (UNII: 65A9F4P024)
EPILOBIUM ANGUSTIFOLIUM FLOWERING TOP (UNII: 08H094218D)
POLYDEXTROSE (UNII: VH2XOU12IE)
CAPRYLOYL GLYCERIN/SEBACIC ACID COPOLYMER (2000 MPA.S) (UNII: N7YC58165T)
SODIUM BENZOATE (UNII: OJ245FE5EU)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID (UNII: 2968PHW8QP)
TRIETHYL CITRATE (UNII: 8Z96QXD6UM)
PHENETHYL ALCOHOL (UNII: ML9LGA7468)
2,6-DIMETHYL-7-OCTEN-2-OL (UNII: 46L1B02ND9)
HELIOTROPINE (UNII: KE109YAK00)
AMYLOPECTIN, UNSPECIFIED SOURCE (UNII: 4XO4QFV777)
CETEARYL OLIVATE (UNII: 58B69Q84JO)
DEXTRAN 1 (UNII: I8LHQ0D645)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
C13-15 ALKANE (UNII: 114P5I43UJ)
SODIUM HYALURONATE (UNII: YSE9PPT4TH)
HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)
GAMMA-UNDECALACTONE (UNII: QB1T0AG2YL)
CETYL ETHYLHEXANOATE (UNII: 134647WMX4)
DIHEPTYL SUCCINATE (UNII: 057N7SS26Y)
POLY-L-LYSINE (30000-70000 MW) (UNII: 0A1V8JTU2M)
DEXTRIN, CORN (UNII: VAD2K35XAJ)
3-HEXENOL (UNII: V14F8G75P4)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 87110-002-01	1 in 1 CARTON	11/18/2025
1		15 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	11/18/2025

Labeler - METHODIQ INC. (119377051)